Silo Pharma, Inc.
SILO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $72 | $72 | $72 | $71 |
| % Growth | 0% | 0% | 1.2% | – |
| Cost of Goods Sold | $6 | $6 | $6 | $5 |
| Gross Profit | $66 | $66 | $66 | $66 |
| % Margin | 91.9% | 91.9% | 91.9% | 93% |
| R&D Expenses | $2,368 | $845 | $1,286 | $694 |
| G&A Expenses | $2,404 | $3,077 | $2,427 | $2,265 |
| SG&A Expenses | $2,404 | $3,077 | $2,427 | $2,265 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$20 | -$149 |
| Operating Expenses | $4,772 | $3,922 | $3,694 | $2,811 |
| Operating Income | -$4,706 | -$3,856 | -$3,628 | -$2,744 |
| % Margin | -6,526.4% | -5,347.4% | -5,031.3% | -3,851% |
| Other Income/Exp. Net | $313 | $225 | -$280 | $6,926 |
| Pre-Tax Income | -$4,393 | -$3,631 | -$3,907 | $4,182 |
| Tax Expense | $0 | $0 | $0 | $25 |
| Net Income | -$4,393 | -$3,701 | -$3,909 | $3,904 |
| % Margin | -6,092.6% | -5,132.6% | -5,420.9% | 5,477.9% |
| EPS | -1.19 | -1.2 | -1.71 | 1.32 |
| % Growth | 0.8% | 29.8% | -229.5% | – |
| EPS Diluted | -1.19 | -1.2 | -1.71 | 1.3 |
| Weighted Avg Shares Out | 3,680 | 3,080 | 2,284 | 1,897 |
| Weighted Avg Shares Out Dil | 3,680 | 3,080 | 2,284 | 1,918 |
| Supplemental Information | – | – | – | – |
| Interest Income | $333 | $399 | $73 | $1 |
| Interest Expense | $5 | $5 | $2 | $3 |
| Depreciation & Amortization | $6 | $0 | $0 | $0 |
| EBITDA | -$4,382 | -$3,626 | -$3,905 | $4,185 |
| % Margin | -6,077% | -5,029.3% | -5,416.2% | 5,872.6% |